{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-034098","form_type":"8-K","ticker":"MTNB","cik":"0001582554","company_name":"Matinas BioPharma Holdings, Inc.","filed_at":"2024-08-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.633782+00:00","generated_at":"2026-05-31T07:11:15.226949+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Matinas BioPharma receives NYSE American trading halt due to low price; plans 1-for-50 reverse split","bullets":["Trading of MTNB common stock halted by NYSE American on August 27, 2024 due to low trading price.","Halt to remain until reverse stock split (1-for-50) is consummated; split effective 5:00 PM EST on August 30, 2024.","Split-adjusted trading expected to begin September 3, 2024, subject to NYSE American approval.","If post-split price does not meet Section 1003(f)(v) requirements, NYSE could suspend trading and delist shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-034098","json":"https://secwatch.observer/filing/0001493152-24-034098.json","markdown":"https://secwatch.observer/filing/0001493152-24-034098.md","text":"https://secwatch.observer/filing/0001493152-24-034098.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1582554/000149315224034098/0001493152-24-034098-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1582554/000149315224034098/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T07:11:15.226949+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}